A Randomized Controlled Trial of Percutaneous Tibial Nerve Stimulation in the Treatment of Female Sexual Dysfunction
- 12 March 2025
- journal article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (4) , 908-913
Abstract
Background: Female sexual dysfunction (FSD) is a prevalent and multifaceted condition affecting women's sexual well‐being. This randomized controlled trial aimed to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) compared to a validated sham control in the treatment of FSD.Methods: We conducted a single‐center randomized controlled trial. Participants with FSD were recruited and randomly assigned at a 1:1 allocation ratio to either PTNS or a validated sham control using transcutaneous nerve stimulation (TENS). Treatment was performed through weekly 30‐min session for 12 weeks total. Sexual function was assessed at baseline, 6 weeks, and 12 weeks primarily using the Female Sexual Function Index (FSFI) questionnaire. Urogenital distress inventory‐6 was collected to evaluate for any baseline urinary incontinence/voiding dysfunction. Linear mixed‐effect models for longitudinal data were used to compare FSFI scores across different time points. Statistical analysis was performed using SAS 9.4 (SAS Institute Inc. Cary, NC).Results: In total, 34 PTNS and 31 TENS subjects were included in our final analysis. Overall, 48% (16/34) of PTNS subjects versus 29% (11/33) of TENS subjects were no longer at risk for FSD (FSFI > 26.55) after 12 weekly treatments. Both PTNS and TENS subjects demonstrated similar improvements in FSFI total scores after 12 weeks of treatments. Interestingly, patients who did not present with baseline urogenital distress symptoms reported a statistically significant larger improvement in sexual satisfaction after PTNS treatments as compared to placebo (p = 0.017).Conclusion: This study demonstrated a sustained efficacy of PTNS in improving sexual function. Specifically, patients who did not have coexisting urinary dysfunction reported significant improvement in sexual satisfaction after PTNS. Our study suggested that PTNS may have a direct neuromodulation effect on sexual dysfunction and may hold promise as a treatment modality for FSD.Keywords
This publication has 13 references indexed in Scilit:
- Medical Treatment of Female Sexual DysfunctionUrologic Clinics of North America, 2022
- Tibial nerve stimulation increases vaginal blood perfusion and bone mineral density and yield load in ovariectomized rat menopause modelInternational Urogynecology Journal, 2022
- Female Sexual DysfunctionObstetrics & Gynecology, 2019
- Female Sexual DysfunctionMedical Clinics of North America, 2019
- Urinary Incontinence and Associated Female Sexual DysfunctionSexual Medicine Reviews, 2017
- Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women with Overactive Bladder SyndromeThe Journal of Sexual Medicine, 2016
- The Impact of Urinary Incontinence and Its Treatment on Female Sexual FunctionCurrent Urology Reports, 2010
- Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT TrialJournal of Urology, 2010
- Validation of a sham for percutaneous tibial nerve stimulation (PTNS)Neurourology and Urodynamics, 2008
- Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve stimulationInternational Journal Of Impotence Research, 2006